SEC Form 3 · accession 0001437749-16-040311

BioCardia, Inc. · BCDA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — VP, Operations

Period of report

Oct 24, 2016

Accepted (ET)

Oct 26, 2016 · 2:06 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000925741

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
No securities beneficially owned^F1	holding	—	—		—	0	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Employee stock option (right to buy)^F2	$0.13	holding	—	—	—	—	Jul 28, 2021	Common Stock	651,823	—	D
Employee stock option (right to buy)^F3	$0.15	holding	—	—	—	—	Jul 9, 2023	Common Stock	27,153	—	D
Employee stock option (right to buy)^F4	$0.15	holding	—	—	—	—	Jul 5, 2024	Common Stock	508,172	—	D
Employee stock option (right to buy)^F5	$0.15	holding	—	—	—	—	Aug 19, 2026	Common Stock	1,141,286	—	D

F1Not applicable.
F2The shares subject to the option are fully vested and immediately exercisable.
F3One-forty-eighth of the shares subject to the option vest on August 1, 2013 and each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.
F4One-forty-eighth of the shares subject to the option vest on August 1, 2014 and each month thereafter, subject to the Reporting Person continuing as a service provider through each such date
F5One-forty-eighth of the shares subject to the option vest on November 24, 2016 and each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.

Exhibit 24 – Power of Attorney